Preview

Федеральные клинические рекомендации "Cиндром Шерешевского-Тернера (СШТ): клиника, диагностика, лечение"

https://doi.org/10.14341/probl201460452-63

Полный текст:

Аннотация

Синдром Шерешевского-Тернера хромосомная патология, обусловленная частичной или полной моносомией. Характерными проявлениями заболевания являются задержка роста, половой инфантилизм и различные врожденные аномалии физического развития. В данных рекомендациях содержатся сведения по этиологии заболевания, пре- и постнатальной диагностике, представлены протоколы наблюдения и лечения пациентов разных возрастных групп.

Об авторе

Н Н Волеводз
ФГБУ «Эндокринологический научный центр» Минздрава России, Москва
Россия


Список литературы

1. Дедов И.И., Петеркова В.А., Волеводз Н.Н. Синдром Шерешевского–Тернера (патогенез, клиника, диагностика, лечение). / Методическое пособие для врачей. – М., 2009. [Dedov II, Peterkova VA, Volevodz NN. Turner syndrome (pathogenesis, clinical manifestations, diagnosis, treatment). Handbook for doctors. Moscow; 2009.]

2. Дедов И.И., Волеводз Н.Н., Малиевский О.А., Петеркова В.А. Опыт использования отечественного препарата Растан при лечении детей с синдромом Шерешевского-Тернера. // Проблемы эндокринологии. 2010;56(3)11-15. [Dedov II, Volevodz NN, Malievskiĭ OA, Peterkova VA. Experience with the use of domestic somatotropin Rastan for the treatment of children with Turner syndrome. Problemy Endokrinologii. 2010;56(3):11-15.] doi: 10.14341/probl201056311-15

3. Волеводз Н.Н. Системные и метаболические эффекты гормона роста у детей с различными вариантами низкорослости: Автореф. дисс. … докт.мед.наук. – М.; 2005. [Volevodz NN. Systemic and metabolic effects of growth hormone on children with different variants of stunting [Dissertation]. Moscow; 2005.]

4. Bondy CA. Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group. The Journal of Clinical Endocrinology & Metabolism. 2007;92(1):10-25. doi: 10.1210/jc.2006-1374

5. Stochholm K, Juul S, Juel K, Naeraa RW, Højbjerg Gravholt C. Prevalence, Incidence, Diagnostic Delay, and Mortality in Turner Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2006;91(10):3897-3902. doi: 10.1210/jc.2006-0558

6. Trolle C, Mortensen KH, Hjerrild BE, Cleemann L, Gravholt CH. Clinical care of adult Turner syndrome--new aspects. Pediatric Endocrinology Reviews. 2012;9 Suppl 2:739-749. PMID:22946288

7. Sybert VP, McCauley E. Turner's Syndrome. New England Journal of Medicine. 2004;351(12):1227-1238. doi: 10.1056/NEJMra030360

8. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, et al. Recommendations for the Diagnosis and Management of Turner Syndrome1. The Journal of Clinical Endocrinology & Metabolism. 2001;86(7):3061-3069. doi: 10.1210/jcem.86.7.7683

9. Baena N, De Vigan C, Cariati E, Clementi M, Stoll C, Caballin MR, et al. Turner syndrome: Evaluation of prenatal diagnosis in 19 European registries. American Journal of Medical Genetics. 2004;129A(1):16-20. doi: 10.1002/ajmg.a.30092

10. Ranke MB, Stubbe P, Majewski F, Bierich JR. Spontaneous Growth in Turner's Syndrome. Acta Paediatrica. 2008;77:22-30. doi: 10.1111/j.1651-2227.1988.tb10796.x

11. Volevodz N, Malievsky O, Peterkova V. Efficacy and safety of use of the domestic somatotropin «Rastan» in girls with Turner s syndrome. Hormone Research in Paediatrics, 2012;78(Suppl 1):324. DOI: 10.1159/000343184

12. Baxter L, Bryant J, Cave CB, Milne R, Bryant J. Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database of Systematic Reviews. 2007 (1):CD003887. doi: 10.1002/14651858.CD003887.pub2

13. Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner syndrome. Archives of Disease in Childhood. 1985;60(10):932-935. doi: 10.1136/adc.60.10.932

14. Gharib H, Cook DM, Saenger PH, Bengtsson BA, Feld S, Nippoldt TB, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Growth Hormone Use in Adults and Children--2003 Update. Endocrine Practice. 2003;9(1):64-76. doi: 10.4158/ep.9.1.64

15. Gravholt CH. Aspects of the treatment of Turner syndrome. Expert Opinion on Pharmacotherapy. 2001;2(10):1633-1647. doi: 10.1517/14656566.2.10.1633

16. Morin A., Guimarey L.M., Apezteguia M., Santucci Z.C. Adult height in Turner Syndrome girls after long-term growth hormone treatment. Medicina (B Aires) 2009;69(4):431-436. PMID:19770097

17. Pasquino AM, Pucarelli I, Segni M, Tarani L, Calcaterra V, Larizza D. Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group. Journal of Endocrinological Investigation. 2014;28(6):350-356. doi: 10.1007/bf03347202

18. Soriano-Guillen L, Coste J, Ecosse E, Léger J, Tauber M, Cabrol S, et al. Adult Height and Pubertal Growth in Turner Syndrome after Treatment with Recombinant Growth Hormone. The Journal of Clinical Endocrinology & Metabolism. 2005;90(9):5197-5204. doi: 10.1210/jc.2005-0470

19. Stephure DK; Canadian Growth Hormone Advisory Committee. Impact of Growth Hormone Supplementation on Adult Height in Turner Syndrome: Results of the Canadian Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 2005;90(6):3360-3366. doi: 10.1210/jc.2004-2187

20. Van den Broeck J, Massa GG, Attanasio A, Matranga A, Chaussain J-L, Price DA, et al. Final height after long-term growth hormone treatment in Turner syndrome. The Journal of Pediatrics. 1995;127(5):729-735. doi: 10.1016/s0022-3476(95)70161-3

21. Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY, et al. Growth Hormone Treatment of Early Growth Failure in Toddlers with Turner Syndrome: A Randomized, Controlled, Multicenter Trial. The Journal of Clinical Endocrinology & Metabolism. 2007;92(9):3406-3416. doi: 10.1210/jc.2006-2874

22. Ranke M.B., Wilton P. Growth homone therapy in KIGS: 10 years experience. Leipzig: Barth 1999.

23. Ranke MB, Lindberg A, Longás AF, Darendeliler F, Albertsson-Wikland K, Dunger D, et al. Major Determinants of Height Development in Turner Syndrome (TS) Patients Treated With GH: Analysis of 987 Patients From KIGS. Pediatric Research. 2007;61(1):105-110. doi: 10.1203/01.pdr.0000250039.42000.c9

24. Betts PR, Butler GE, Donaldson MDC, Dunger DB, Johnston DI, Kelnar CJH, et al. A decade of growth hormone treatment in girls with Turner syndrome in the UK. Archives of Disease in Childhood. 1999;80(3):221-225. doi: 10.1136/adc.80.3.221

25. Hsu P-Y, Tung Y-C, Tsai W-Y, Lee J-S, Hsiao P-H. Effect of Growth Hormone Therapy on Adult Height of Children with Turner Syndrome. Journal of the Formosan Medical Association. 2008;107(9):704-709. doi: 10.1016/s0929-6646(08)60115-1

26. Khadilkar VV, Khadilkar AV, Nandy M, Maskati GB. Growth hormone in Turner syndrome. Indian Pediatrics. 2006;43(3):236-240. PMID:16585818

27. Carel J-C, Mathivon L, Gendrel C, Ducret J-P, Chaussain J-L. Near Normalization of Final Height with Adapted Doses of Growth Hormone in Turner’s Syndrome. The Journal of Clinical Endocrinology & Metabolism. 1998;83(5):1462-1466. doi: 10.1210/jcem.83.5.4777

28. Hochberg Z, Zadik Z. Final height in young women with Turner syndrome after GH therapy: an open controlled study. European Journal of Endocrinology. 1999;141(3):218-224. doi: 10.1530/eje.0.1410218

29. Rosenfeld RG, Attie KM, Frane J, Brasel A, Burstein S, Cara JF, et al. Growth hormone therapy of Turner's syndrome: Beneficial effect on adult height. The Journal of Pediatrics. 1998;132(2):319-324. doi: 10.1016/s0022-3476(98)70452-4

30. Sas TCJ, de Muinck Keizer-Schrama SMPF. Turner’s Syndrome: A Paediatric Perspective. Hormone Research. 2001;56(Suppl. 1):38-43. doi: 10.1159/000048133

31. Quigley CA, Crowe BJ, Anglin DG, Chipman JJ. Growth Hormone and Low Dose Estrogen in Turner Syndrome: Results of a United States Multi-Center Trial to Near-Final Height. Journal of Clinical Endocrinology and Metabolism. 2002 May;87(5):2033-2041. doi: 10.1210/jc.87.5.2033

32. Nadeem M, Roche EF. Bone health in children and adolescent with Turner syndrome. Journal of Pediatric Endocrinology and Metabolism. 2012;25(9-10). doi: 10.1515/jpem-2012-0088

33. Knickmeyer RC. Turner syndrome. Current Opinion in Neurology. 2012;25(2):144-149. doi: 10.1097/WCO.0b013e3283515e9e

34. Ranke MB, Schweizer R, Martin DD, Ehehalt S, Schwarze C-P, Serra F, et al. Analyses from a Centre of Short- and Long-Term Growth in Turner's Syndrome on Standard Growth Hormone Doses Confirm Growth Prediction Algorithms and Show Normal IGF-I Levels. Hormone Research in Paediatrics. 2012;77(4):214-221. doi: 10.1159/000336806


Для цитирования:


Волеводз Н.Н. Федеральные клинические рекомендации "Cиндром Шерешевского-Тернера (СШТ): клиника, диагностика, лечение". Проблемы Эндокринологии. 2014;60(4):65-76. https://doi.org/10.14341/probl201460452-63

For citation:


Volevodz N.N. Federal clinical practice guidelines on the diagnostics and treatment of Shereshevsky-Turner syndrome. Problems of Endocrinology. 2014;60(4):65-76. (In Russ.) https://doi.org/10.14341/probl201460452-63

Просмотров: 25


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)